|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| A61K 31/23 | (2006.01) | ||
| A61K 31/7004 | (2006.01) |
| (11) | Patento numeris | 2650381 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13167177.8 |
| Europos patento paraiškos padavimo data | 2008-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 953074 P | 2007-07-31 | US |
| (72) |
Henderson, Samuel T., US
|
| (73) |
Accera, Inc.,
380 Interlocken Crescent, Suite 780, Broomfield, Colorado 80021,
US
|
| (54) | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |